Chugai Pharmaceutical Co. Ltd: PharmaVitae Profile

This analysis examines the historical and forecast performance for Chugai in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

• The Top 10 Biosimilar Players (08/12/2009)
• New Approaches to Pharma R&D (08/12/2009)
• The Top 10 Generic Pharmaceutical (14/10/2008)

• Bristol-Myers Squibb Co. (09/10/2008)
• Pfizer Inc. (07/10/2008)
• Genentech Inc. (07/10/2008)

• Boehringer Ingelheim GmbH (07/10/2008)
• Abbott Laboratories (07/10/2008)
• Eli Lilly & Co. (07/10/2008)
• GlaxoSmithKline (07/10/2008)
• Clinical Trial Design (10/06/2008)
• Benchmarking Patent Expiries (21/05/2008)
• Disease Management and Drug Adherence (20/05/2008)
• R&D Strategies (20/05/2008)
• Business Blogging for Pharma (20/05/2008)

---